Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isentress + Truvada tolerability study for HIV post-exposure prophylaxis
2009-017742-31Phase 3Active
- Sponsor
- GERES
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of raltegravir and emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by GERES. Started Apr 2010; status: active.
02
Drugs
raltegraviremtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2009-017742-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017742-31.